Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blue Biofuels has demonstrated successful conversion of various biomass feedstocks—including king grass, sugarcane bagasse, and corn stover—into fermentable sugars using its CTS process. These sugars have been fermented into ethanol in high yield at the pilot scale. The company’s patented technology shows flexibility across different feedstocks with no harmful byproducts inhibiting fermentation. Engineering plans are underway for a commercial facility targeting an annual output of three million gallons of biofuel. The company holds seven granted patents with an additional twenty-five pending as of June 2025. A U.S. Department of Energy grant supports their current facility development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blue Biofuels.